Cardiovascular risks of anti-VEGF appear similar to those of treatment alternatives

For patients with diabetic retinopathy, intravitreal anti-VEGF injections appear to have largely similar cardiovascular risks as steroid or laser treatments, but there is one caveat.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553